Royce Small-Cap Total Return—2Q25 Update and Outlook—Royce
article 07-29-2025

Royce Small-Cap Total Return—2Q25 Update and Outlook

Lead Portfolio Manager Miles Lewis, Portfolio Manager Joe Hintz, and Assistant Portfolio Manager Jag Sriram update investors on a solid quarter and their cautious outlook.

TELL US
WHAT YOU
THINK

How did Royce Small-Cap Total Return Fund in 2Q25 and over longer-term periods?

Miles Lewis: The Fund, which is part of Royce’s Quality Value Strategy, advanced 2.7% for the quarter, lagging its benchmark, Russell 2000 Value Index, which was up 5.0% for the same period. The portfolio also trailed the Russell 2000 Value Index slightly for the year-to-date period ended 6/30/25, down -3.4% versus -3.2%. However, the Fund outperformed its benchmark for the 3-, 5-, 10-, 15-, 20-, 25-, 30-year, and since inception (12/15/93) periods ended 6/30/25.

How did performance shake out at the sector and industry level in 2Q25?

Joe Hintz: Seven of the portfolio’s 10 equity sectors made a positive impact on quarterly performance, led by Information Technology, Industrials, and Financials while the largest negative impacts came from Energy, Real Estate, and Consumer Staples.

What about for the Fund’s industry groups?

Jag Sriram: Banks (Financials), trading companies & distributors (Industrials), and capital markets (Financials) contributed most in the second quarter, while financial services (Financials), professional services (Industrials), and energy equipment & services (Energy) were the largest detractors.

Which holding contributed most in 2Q25?

ML: The Fund’s top contributor was Healthcare Services Group, which provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments of nursing homes, retirement communities, rehabilitation centers, and hospitals in the U.S. In April, management reported the company’s best quarterly revenue and cash flow performance in five years, driven in part by the post-covid recovery in the nursing home industry, strong retention rates, new customer acquisitions, and opportunities for cross-selling.

“We continue to build the portfolio using our robust and repeatable research process and feel that our bottom-up focus on constructing the portfolio with high-quality companies that trade at undemanding valuations can drive solid returns regardless of the macro environment.”
—Miles Lewis

Which holding detracted most in the second quarter?

JH: Our top detractor was Vestis Corporation, which provides uniform rentals and workplace supplies in the U.S. and Canada. Its shares fell sharply in May when the company reported poor results for its fiscal second quarter, which included a cessation of its dividend and a down shift to negative earnings per share and led us to exit the position.

At the sector level, how did the Fund perform versus its benchmark?

JS: Our disadvantage versus the Russell 2000 Value came from stock selection. At the sector level, stock selection detracted the most in Financials, Industrials, and Information Technology. Conversely, our substantially lower exposure to Real Estate, a lower exposure and stock selection in Health Care, and lack of exposure to Utilities were all additive vis-à-vis the benchmark.

How did the Fund perform at the sector level for the year-to-date period ended 6/30/25?

ML: Seven of the Fund’s 10 equity sectors made a negative impact on year-to-date period performance, with Consumer Discretionary, Energy, and Industrials detracting most while the largest positive impacts came from Financials, Information Technology, and Health Care.

What were the biggest industry contributors and detractors in the year-to-date period?

JH: Professional services (Industrials), financial services (Financials), and energy equipment & services (Energy) detracted most for the year-to-date period, while capital markets (Financials), trading companies & distributors (Industrials), and banks (Financials) were the largest contributors.

Which holding detracted and contributed most from performance in the year-to-date period?

JS: There was a rare instance of the same two holdings being the top detractor and contributor: Vestis Corporation was the top detractor, and Healthcare Services Group was the top contributor.

What were the sources of the Fund’s slight disadvantage versus the Russell 2000 Value in the year-to-date period ended 6/30/25?

JH: The disadvantage was attributable to stock selection. At the sector level, stock selection in Consumer Discretionary, a lack of exposure to Utilities, and stock selection in Industrials hurt relative results most while lower exposure (with an assist from stock selection) to Health Care, an underweight in Energy, and higher exposure to Financials were additive versus the Russell 2000 Value.

What is the outlook for the Fund?

JH: The second quarter regained much of the lost ground from the first quarter, as investors seemed to gain comfort despite continued U.S. policy and tariff uncertainty. However, underneath the surface there was a significant dispersion of returns across the market, with low-quality and high-beta driving much of the returns in the small-cap universe. Within the Russell 2000 Value, Information Technology led by a wide margin, with Materials following in a distant second place in the quarter. While the Fund has an overweight position within the IT sector, the strength of the sector within the small-cap value index came mostly from massive share price swings in more speculative growth-type companies with negative earnings. Given our focus on high-quality companies with strong financial characteristics, we would not expect to outperform in such a big risk-on market. (For reference, the Russell 2000 Value rallied 20.2% from the 4/8/25 bottom through the end of June.) We continue to hold a somewhat cautious view entering the third quarter.

ML: As we have previously discussed, the un-inverting of the yield curve near the end of last year may not have been a positive development. Not only has it historically signaled the presence or imminent arrival of recessions going back to 1980, but it is also another data point in a current environment that has a plethora of mixed signals, making the subsequent direction of the economy and capital markets even tougher to gauge than usual. Furthermore, while 1Q25 earnings were not nearly as bad as many had feared following the tariff announcements on 4/2/25 and the concurrent market swoon, we think that risks remain elevated from U.S. trade policy and overall geopolitical tensions. We continue to build the portfolio using our robust and repeatable research process and feel that our bottom-up focus on constructing the portfolio with high-quality companies that trade at undemanding valuations can drive solid returns regardless of the macro environment. We think that our overweight within insurance offers a perfect example of this view, particularly within the lens of second quarter performance. The overweight was a detractor in the quarter, predominantly because the industry’s defensive characteristics worked against it in a low-quality rally. That being said, we don’t own this group of companies predominantly for their defensive characteristics, but rather because each holding company operates within a unique niche and has a strong management team, which we think will lead to idiosyncratic opportunities in the long run.

Important Disclosure Information

Average Annual Total Returns as of 6/30/2025 (%)

  QTD1 1YR 3YR 5YR 10YR SINCE
INCEPT.
DATE ANNUAL
OPERATING EXPENSES
NET               GROSS
Small-Cap Total Return 2.74 4.84 9.81 12.56 7.84 9.97 12/15/93  1.21  1.21
Russell 2000 Value
4.97 5.54 7.45 12.47 6.72 9.11 N/A  N/A  N/A
Russell 2000
8.50 7.68 10.00 10.04 7.12 8.56 N/A  N/A  N/A
1 Not annualized.

All performance information reflects past performance, is presented on a total return basis, reflects the reinvestment of distributions, and does not reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption of fund shares. Past performance is no guarantee of future results. Investment return and principal value of an investment will fluctuate, so that shares may be worth more or less than their original cost when redeemed. Current month-end performance may be higher or lower than performance quoted and may be obtained at www.royceinvest.com. Operating expenses reflect the Fund's total annual operating expenses for the Investment Class as of the Fund's most current prospectus and include management fees, other expenses, and acquired fund fees and expenses. Acquired fund fees and expenses reflect the estimated amount of the fees and expenses incurred indirectly by the Fund through its investments in mutual funds and other investment companies.

Mr. Lewis’s, Mr. Hintz’s, and Mr. Sriram’s thoughts and opinions concerning the stock market are solely their own and, of course, there can be no assurance with regard to future market movements. No assurance can be given that the past performance trends as outlined above will continue in the future.

The performance data and trends outlined in this presentation are presented for illustrative purposes only. Past performance is no guarantee of future results. Historical market trends are not necessarily indicative of future market movements.

Percentage of Fund Holdings As of 6/30/25 (%)

  Small-Cap Total Return

Healthcare Services Group

4.1

Vestis Corporation

0.0

Company examples are for illustrative purposes only. This does not constitute a recommendation to buy or sell any stock. There can be no assurance that the securities mentioned in this piece will be included in any Fund’s portfolio in the future.

Sector weightings are determined using the Global Industry Classification Standard ("GICS"). GICS was developed by, and is the exclusive property of, Standard & Poor's Financial Services LLC ("S&P") and MSCI Inc. ("MSCI"). GICS is the trademark of S&P and MSCI. "Global Industry Classification Standard (GICS)" and "GICS Direct" are service marks of S&P and MSCI.

Frank Russell Company (“Russell”) is the source and owner of the trademarks, service marks and copyrights related to the Russell Indexes. Russell® is a trademark of Frank Russell Company. Neither Russell nor its licensors accept any liability for any errors or omissions in the Russell Indexes and / or Russell ratings or underlying data and no party may rely on any Russell Indexes and / or Russell ratings and / or underlying data contained in this communication. No further distribution of Russell Data is permitted without Russell’s express written consent. Russell does not promote, sponsor or endorse the content of this communication. All indexes referenced are unmanaged and capitalization weighted. The Russell 2000 Index is an index of domestic small-cap stocks that measures the performance of the 2,000 smallest publicly traded U.S. companies in the Russell 3000 Index. The Russell 2000 Value index consists of the respective value stocks within the Russell 2000 as determined by Russell Investments. The performance of an index does not represent exactly any particular investment, as you cannot invest directly in an index.

This material is not authorized for distribution unless preceded or accompanied by a current prospectus. Please read the prospectus carefully before investing or sending money. The Fund invests primarily in small-cap stocks, which may involve considerably more risk than investing in larger-cap stocks. (Please see "Primary Risks for Fund Investors" in the prospectus.) The Fund’s broadly diversified portfolio does not ensure a profit or guarantee against loss. The Fund may invest up to 25% of its net assets (measured at the time of investment) in securities of companies headquartered in foreign countries, which may involve political, economic, currency, and other risks not encountered in U.S. investments. (Please see "Investing Foreign Securities" in the prospectus.)

Share:

Subscribe:

Sign Up

Follow: